ArcaScience raises $7M to expand AI benefit risk platform in drug development
French artificial intelligence healthtech startup ArcaScience SAS revealed today that it has raised $7 million in new funding to expand into the U.S. and the U.K., launch a patient-facing solution for pediatric brain cancer and dermatological diseases,and hire a chief medical officer. Founded in 2018, ArcaScience is an AI-first healthtech startup that has been built […] The post ArcaScience raises $7M to expand AI benefit risk platform in drug development appeared first on SiliconANGLE.| SiliconANGLE
